CytoDyn Inc.
For the period ended Feb 28, 2025. Filed Apr 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 28, 2025 · Filed Apr 14, 2025
CYDYStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. EXHIBITS
(a)Exhibits:
| | | | | | | | | |
| | | | | | | Incorporated by Reference | ||
| ExhibitNo | Description | | FiledHerewith | | Form | Exhibit No. | Filing Date | |
| | | | | | | | | |
| 10.1 | | Amendment to Security Agreement between CytoDyn Inc. and Streeterville Capital, LLC, dated April 2, 2021 | | X | | | | |
| | | | | | | | | |
| 10.2 | | Amendment to Security Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021 | | X | | | | |
| | | | | | | | | |
| 31.1 | | Rule 13a-14(a) Certification by Principal Executive Officer of the Registrant. | | X | | | | |
| 31.2 | | Rule 13a-14(a) Certification by Principal Financial Officer of the Registrant. | | X | | | | |
| | | | | |||||
| 32 | | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.* | | X | | | | |
| | | | | | | | | |
| 101.INS | | Inline XBRL Instance Document. | | X | | | | |
| | | | | |||||
| 101.SCH | | Inline XBRL Taxonomy Extension Schema Document. | | X | | | | |
| | | | | |||||
| 101.CAL | | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | | X | | | | |
| | | | | |||||
| 101.DEF | | Inline XBRL Taxonomy Extension Definition Linkbase Document. | | X | | | | |
| | | | | | | | | |
| 101.LAB | | Inline XBRL Taxonomy Extension Label Linkbase Document. | | X | | | | |
| | | | | | | | | |
| 101.PRE | | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | | X | | | | |
| | | | | | | | | |
| 104 | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | | X | | |||
*Furnished, not filed.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CYTODYN INC. | ||
| (Registrant) | ||
| Dated: April 14, 2025 | /s/ Jacob Lalezari | |
|---|---|---|
| Jacob Lalezari | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| Dated: April 14, 2025 | /s/ Mitchell Cohen |
|---|---|
| Mitchell Cohen | |
| Interim Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.